The Horseracing Integrity & Welfare Unit (HIWU) has suspended the Pennsylvania Equine Toxicology and Research Laboratory's (PETRL) probationary Horseracing Integrity and Safety Authority (HISA) Equine Analytical Laboratory (HEAL) accreditation status for a minimum of six months, beginning July 8, 2025, the organization announced in a release Wednesday morning. Effective immediately, samples collected in Pennsylvania are being sent to Industrial Laboratories for analysis.
HIWU's independent Laboratory Expert Group, which evaluates the performance of Program laboratories, recommended the suspension of PETRL's probationary HEAL accreditation due to nonconformities associated with HEAL compliance. HIWU, in consultation with its Laboratory Expert Group, will review PETRL's response to this suspension and associated corrective actions. Probationary accreditation status will not be restored unless and until the laboratory is in full compliance with HEAL.
HIWU's review of PETRL is ongoing, and any impact on resolved or pending ADMC Program cases will be publicly disclosed in accordance with Program rules.
The HEAL accreditation program was implemented on January 1, 2025, and is the national laboratory accreditation program established by HISA's Anti-Doping and Medication Control Program. Overseen by HIWU, it builds on the foundations of the ISO 17025 and Racing Medication & Testing Consortium models and requires a robust External Quality Assessment Scheme to ensure that Program laboratories maintain HEAL standards.
Not a subscriber? Click here to sign up for the daily PDF or alerts.
